Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of recombinant hCG versus recombinant hCG plus GnRH agonist in poor responder endometriosis patients undergoing fertility treatment
IRCT20091012002576N22Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of recombinant human chorionic gonadotrophin in female infertility and endometriosis (2 arms), sponsored by Tehran University of Medical Sciences. Started Feb 2022; status: completed.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
female infertilityendometriosis
Beyond the preview
Go deeper on IRCT20091012002576N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N22.